Tags : BMS-Pfizer Alliance

PharmaShots Weekly Snapshot (October 14-18, 2019)

Vartika Singh October 21, 2019

1. Johnson & Johnson Initiates Voluntarily Recall of a Single Lot of its Baby Powder in the US Published: Oct 18, 2019 | Tags: JnJ, Initiates, Voluntarily, Recall, Baby Powder, US […]readmore

DigiHealth

Fitbit Collaborates with BMS-Pfizer Alliance Focusing on Improving Atrial Fibrillation

Vartika Singh October 18, 2019

Shots: The BMS-Pfizer Alliance and Fitbit collaborate to develop educational content and guidance, supporting patients with a high risk of AFib. The companies will focus on providing information to encourage […]readmore

Tags : BMS-Pfizer Alliance

PharmaShots Weekly Snapshot (October 14-18, 2019)

Fitbit Collaborates with BMS-Pfizer Alliance Focusing on Improving Atrial Fibrillation

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : BMS-Pfizer Alliance

﻿PharmaShots Weekly Snapshot (October 14-18, 2019)

Fitbit Collaborates with BMS-Pfizer Alliance Focusing on Improving Atrial Fibrillation

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company

PharmaShots Weekly Snapshot (October 14-18, 2019)